Export-Controlled Biological Materials and Chemicals

“Australia Group” viruses (ECCN 1C351.a)

• African horse sickness virus
• African swine fever virus
• Andes virus
  • AI viruses that have an intravenous pathogenicity index (IVPI) in 6-week-old chickens greater than 1.2; or
  • AI viruses that cause at least 75% mortality in 4-to 8-week old chickens infected intravenously.
• Bluetongue virous
• Chapare virus
• Chikungunya virus
• Choclo virus
• Classical swine fever virus (Hog cholera virus)
• Crimean-Congo hemorrhagic fever virus
• Dobrava-Belgrade virus
• Eastern equine encephalitis virus
• Ebolavirus (includes all members of the Ebolavirus genus)
• Foot-and-mouth disease virus
• Goatpox virus
• Guanarito virus
• Hantaan virus
• Hendra virus (Equine morbillivirus)
• Japanese encephalitis virus
• Junin virus
• Kyasanur Forest disease virus
• Laguna Negra virus
• Lassa virus
• Louping il virus
• Lujo virus
• Lumpy skin disease virus
• Lymphocytic Choriomeningitis virus
• Machupo virus
• Barburgvirus (includes all members of the Marburgvirus genus)
• Middle East respiratory syndrome-related coronavirus (MERS-related coronavirus)
• Monkeypox virus
• Murray Valley encephalitis virus
• Newcastle disease virus
• Nipah virus
• Omsk hemorrhagic fever virus
• Oropuche virus
• Peste-des-petits ruminants virus
• Porcine Teschovirus
• Powassan virus
• Rabies virus and all other members of the Lyssavirus genus
• Reconstructed 1918 influenza virus
• Rift Valley fever virus
• Rinderpest virus
• Rocio virus
• Sabia virus
• Seoul virus
• Severe acute respiratory syndrome-related coronavirus (SARS-related coronavirus)
• Sheeppox virus
• Sin Nombre virus
• St. Louis encephalitis virus
• Suid herpesvirus 1 (Pseudorabies virus; Aujeszky’s disease)
• Swine vesicular disease virus
• Tick-borne encephalitis (Far Eastern subtype, formerly known as Russian Spring-Summer encephalitis virus
• Variola virus
• Venezuelan equine encephalitis
• Vesicular stomatitis virus
• Western equine encephalitis
• Yellow fever virus

Viruses identified on APHIS/CDC “select agents list” but not listed in Australia Group (1C351.b)

• Tick-borne encephalitis virus (Siberian subtype, formerly West Siberian virus)

Genetically modified organisms that contain, or any genetic element that codes for, any gene or genes specific to the viruses listed above (1C353)

Plant Viruses (ECCN 1C354.c)

• Potato spindle tuber viroid
• Andean potato latent virus (Potato Andean latent tymovirus)

“Australia Group” Bacteria (1C351.c.)

• Bacillus anthracis
• Brucella abortus
• Brucella melitensis
• Brucella suis
• Burkholderia mallei (Pseudomonas mallei)
• Burkholderia pseudomallei (Pseudomonas pseudomallei)
• Chlamydia psittaci (Chlamydophila psittaci)
• Clostridium argentinense (formerly known as Clostridium botulinum Type G), botulinum neurotoxin producing strains
• Clostridium baratii, botulinum neurotoxin producing strains
• Clostridium botulinum
• Clostridium butyricum, botulinum neurotoxin producing strains
• Clostridum perfringens, epsilon toxin producing types
• Coxiella burnetiid
• Francisella tularensis
• Mycoplasma capricolum subspecies capripneumoniae (“strain F38”)
• Mycoplasma mycoides subspecies mycoides SC (small colony) (a.k.a. contagious bovine pleuropneumonia)
• Rickettsia prowazekii
• Salmonella enterica subspecies enterica serovar Typhi (Salmonella typhi)
• Shiga toxin producing Escherichia coli (STEC) of serogroups O26, O45, O103, O104, O111, O121, O145, O157, and other shiga toxin producing serogroups
• Shigella dysenteriae
• Vibrio cholerae
• Yersinia pestis

Plant Bacteria (1C354.a)

• Xanthomonas albilineans
• Xanthomonas citri pv. citri (Xanthomonas axonopodis pv. citri, Xanthomonas campestris pv. citri)
• Xanthomonasl oryzae
• Clavibacter michiganensis subspecies sepedonicus (syn. Corynebacterium michiganensis subspecies sepedonicum or Corynebacterium sepedonicum)
• Ralstonia solanacearum, race 3, biovar 2
• Raythayibactor toxicus

Toxins (1C351.d)

• Abrin
• Aflatoxins
• Botulinum toxins
• Brevetoxins
• Clostridium perfringens alpha, beta 1, beta 2, epsilon and iota toxins
• Conotoxins
• Diacetoxyscirpenol
• Gonyautoxins
• HT-2 toxin
• Microcystins (Cyanginosins)
• Modeccin
• Nodularins
• Palytoxin
• Ricin
• Saxitoxin
• Shiga toxins (shiga-like toxins, verotoxins, and verocytotoxins)
• Staphylococcus aureus enterotoxins, hemolysin alpha toxin, and toxic shock syndrome toxin (formerly known as Staphylococcus enterotoxin F)
• T-2 toxin
• Tetrodotoxin
• Viscumin (Viscum album lectin 1)
• Volkensin

Fungi (1C351.e)

• Coccidioides immitis
• Coccidioides posadasii

Plant Fungi (ECCN 1C354.b)

• Bipolariz oryzae (Cochliobolus miyabeanus, Helminthosporium oryzae)
• Colletotrichum kahawae (Colletotrichum coffeanum var. virulans)
• Pseudocercospora ulei (Microcyclus ulei, Dothidella ulei)
• Puccinnia graminis ssp. graminis var. graminis/Puccinia graminis ssp. graminis var. stakmanii (Puccinia graminis [syn. Puccinia graminis f. sp. tritici])
• Puccinia striiformis (syn. Puccinia glumarum)
• Magnaporthe oryzae (Pyricularia oryzae)
• Peronosclerospora philippinensis (Peronosclerospora sacchari)
• Sclerophthora rayssiae var. zeae
• Synchytrium endobioticum
• Tilletia indica
• Thecaphora solani
• Phoma glycinicola

Medical Products that Contain Any of the Following:

• Toxins or their subunits listed in this document (does not apply to botulinum toxins or conotoxins)
• Genetically modified organisms or genetic elements
• Genetic elements that code for any toxins or their subunits listed in this document (does not apply to botulinum toxins or conotoxins)

• Nerve agents, as follows:
  • O-Alkyl (equal to or less than C10, including cycloalkyl) alkyl (Methyl, Ethyl, n-Propyl or Isopropyl) phosphonofluoridates, such as: Sarin (GB): O-Isopropyl methylphosphonofluoridate (CAS 107-44-8) (CWC Schedule 1A); and Soman (GD): O-Pinacolyl methylphosphonofluoridate (CAS 96-64-0) (CWC Schedule 1A);
  • O-Alkyl (equal to or less than C10, including cycloalkyl) N,N-dialkyl (Methyl, Ethyl, n-Propyl or Isopropyl) phosphoramidocyanidates, such as: Tabun (GA): O-Ethyl N, N-dimethylphosphoramidocyanidate (CAS 77-81-6) (CWC Schedule 1A); or
  • O-Alkyl (H or equal to or less than C10, including cycloalkyl) S-2-dialkyl (Methyl, Ethyl, n-Propyl or Isopropyl) aminoethyl alkyl (Methyl, Ethyl, n-Propyl or Isopropyl) phosphonothiolates and corresponding alkylated and protonated salts, such as VX: O-Ethyl S-2-diisopropylaminoethyl methyl phosphonothiolate (CAS 50782-69-9) (CWC Schedule 1A);
• Amiton: O,O-Diethyl S-[2(diethylamino)ethyl] phosphorothiolate and corresponding alkylated or protonated salts (CAS 78-53-5) (CWC Schedule 2A);
• Vesicant agents, as follows:
  • Sulfur mustards, such as: 2-Chloroethylchloromethylsulfide (CAS 2625-76-5) (CWC Schedule 1A); Bis(2-chloroethyl)sulfide (HD) (CAS 505-60-2) (CWC Schedule 1A); Bis(2-chloroethylthio)methane (CAS 63839-13-6) (CWC Schedule 1A); 1,2-bis (2-chloroethylthio)ethane (CAS 3563-36-8) (CWC Schedule 1A); 1,3-bis (2-chloroethylthio)-n-propane (CAS 63905-10-2) (CWC Schedule 1A); 1,4-bis (2-chloroethylthio)-n-butane (CWC Schedule 1A); 1,5-bis (2-chloroethylthio)-n-pentane (CWC Schedule 1A); Bis (2-chloroethylthiomethyl)ether (CWC Schedule 1A); Bis (2-chloroethylthioethyl)ether (CAS 63918-89-8) (CWC Schedule 1A);
  • Lewisites, such as: 2-chlorovinyldichloroarsine (CAS 541-25-3) (CWC Schedule 1A); Tris (2-chlorovinyl) arsine (CAS 40334-70-1) (CWC Schedule 1A); Bis (2-chlorovinyl) chloroarsine (CAS 40334-69-8) (CWC Schedule 1A);
    • Nitrogen mustards, or their protonated salts, as follows:
    • HN1: Bis (2-chloroethyl) ethylamine (CAS 538-07-8) (CWC Schedule 1A);
    • HN2: Bis (2-chloroethyl) methylamine (CAS 51-75-2) (CWC Schedule 1A);
    • HN3: Tris (2-chloroethyl) amine (CAS 555-77-1) (CWC Schedule 1A); or
    • Other nitrogen mustards, or their salts, having a propyl, isopropyl, butyl, isobutyl, or tertiary butyl group on the bis(2-chloroethyl) amine base;
  • Ethyldichloroarsine (ED) (CAS 598-14-1); or
  • Methyldichloroarsine (MD) (CAS 593-89-5);
• Incapacitating agents, such as:
  • 3-Quinuclindinyl benzilate (BZ) (CAS 6581-06-2) (CWC Schedule 2A);
  • Diphenylchloroarsine (DA) (CAS 712-48-1); or
  • Diphenylcyanoarsine (DC) (CAS 23525-22-6);
• Chemical warfare agents not enumerated above adapted for use in war to produce casualties in humans or animals, degrade equipment, or damage crops or the environment. (See the CCL at ECCNs 1C350, 1C355, and 1C395 for control of certain chemicals not adapted for use in war.)

• Genetically modified biological agents:
  • Having non-naturally occurring genetic modifications that are known to or are reasonably expected to result in an increase in any of the following:
    • Persistence in a field environment (i.e., resistance to oxygen, UV damage, temperature extremes, arid conditions, or decontamination processes); or
    • The ability to defeat or overcome standard detection methods, personnel protection, natural or acquired host immunity, host immune response, or response to standard medical countermeasures; and
  • Being any micro-organisms/toxins or their non-naturally occurring genetic elements as listed below:
    • Bacillus anthracis;
    • Botulinum neurotoxin producing species of Clostridium;
    • Burkholderia mallei;
    • Burkholderia pseudomallei;
    • Ebola virus;
    • Foot-and-mouth disease virus;
    • Francisella tularensis;
    • Marburg virus;
    • Variola major virus (Smallpox virus);
    • Variola minor virus (Alastrim);
    • Yersinia pestis; or
    • Rinderpest virus.
• Biological agent or biologically derived substances controlled in ECCNs 1C351, 1C353, or 1C354:
  • Physically modified, formulated, or produced as any of the following:
  • 1-10 micron particle size;
  • Particle-absorbed or combined with nano-particles;
  • Having coatings/surfactants, or
  • By microencapsulation; and
• Meeting the criteria of paragraph (b)(2)(i) of this category in a manner that is known to or is reasonably expected to result in an increase in any of the following:
  • Persistence in a field environment (i.e., resistant to oxygen, UV damage, temperature extremes, arid conditions, or decontamination processes);
  • Dispersal characteristics (e.g., reduced susceptibility to shear forces, optimized electrostatic charges); or
  • The ability to defeat or overcome: standard detection methods, personnel protection, natural or acquired host immunity, or response to standard medical countermeasures.

1. Alkyl (Methyl, Ethyl, n-Propyl or Isopropyl) phosphonyl difluorides, such as: DF: Methyl Phosphonyldifluoride (CAS 676-99-3) (CWC Schedule 1B); Methylphosphinyldifluoride (CAS 753-59-3) (CWC Schedule 2B);
2. O-Alkyl (H or equal to or less than C10, including cycloalkyl) O-2-dialkyl (methyl, ethyl, n-Propyl or isopropyl) aminoethyl alkyl (methyl, ethyl, N-propyl or isopropyl) phosphonite and corresponding alkylated and protonated salts, such as QL: O-Ethyl-2-di-isopropylaminoethyl methylphosphonite (CAS 57856-11-8) (CWC Schedule 1B);
3. Chlorosarin: O-Isopropyl methylphosphonochloridate (CAS 1445-76-7) (CWC Schedule 1B);
4. Chlorosoman: O-Pinacolyl methylphosphonochloridate (CAS 7040-57-5) (CWC Schedule 1B); or
5. Methylphosphonyl dichloride (CAS 676-97-1) (CWC Schedule 2B); Methylphosphinyldichloride (CAS 676-83-5) (CWC Schedule 2B). 

1. 2,4,5-trichlorophenoxyacetic acid (CAS 93-76-5) mixed with 2,4-dichlorophenoxyacetic acid (CAS 94-75-7) (Agent Orange (CAS 39277-47-9)); or
2. Butyl 2-chloro-4-fluorophenoxyacetate (LNF).

• Any equipment for the dissemination, dispersion, or testing of articles controlled in paragraphs (a), (b), (c), or (e) of this category, as follows:
  • Any equipment “specially designed” for the dissemination and dispersion of articles controlled in paragraphs (a), (b), (c), or (e) of this category; or
  • Any equipment “specially designed” for testing the articles controlled in paragraphs (a), (b), (c), (e), or (f)(4) of this category and developed under a Department of Defense contract or other funding authorization.
• Any equipment, containing reagents, algorithms, coefficients, software, libraries, spectral databases, or alarm set point levels developed under a Department of Defense contract or other funding authorization, for the detection, identification, warning, or monitoring of:
  • Articles controlled in paragraphs (a) or (b) of this category; or
  • Chemical agents or biological agents specified in the Department of Defense contract or other funding authorization.
• For individual protection or collective protection against the articles controlled in paragraphs (a) and (b) of this category, as follows:
  • M53 Chemical Biological Protective Mask or M50 Joint Service General Purpose Mask (JSGPM);
  • Filter cartridges containing sorbents controlled in paragraph (f)(4)(iii) or (n) of this category;
  • Carbon meeting MIL-DTL-32101 specifications (e.g., ASZM-TEDA carbon); or
  • Ensembles, garments, suits, jackets, pants, boots, or socks for individual protection, and liners for collective protection that allow no more than 1% breakthrough of GD or no more than 2% breakthrough of any other chemical controlled in paragraph (a) of this category, when evaluated by executing the applicable standard method(s) of testing described in the current version of Test Operating Protocols (TOPs) 08-2-201 or 08-2-501 and using the defined Department of Defense-specific requirements;
• Chemical Agent Resistant Coatings that have been qualified to military specifications (MIL-PRF-32348, MIL-DTL-64159, MIL-C-46168, or MIL-DTL-53039); or
• Any part, component, accessory, attachment, equipment, or system that:
  • Is classified;
  • Is manufactured using classified production data; or
  • Is being developed using classified information.

1. When exclusively funded by a Department of Defense contract for detection of the biological agents at paragraph (b)(1)(ii) of this category even if naturally occurring;
2. Joint Biological Agent Identification and Diagnostic System (JBAIDS) Freeze Dried reagents listed by JRPD-ASY-No and Description respectively as follows:
   • JRPD-ASY-0016 Q-Fever IVD Kit;
   • JRPD-ASY-0100 Vaccinia (Orthopox);
   • JRPD-ASY-0106 Brucella melitensis (Brucellosis);
   • JRPD-ASY-0108 Rickettsia prowazekii (Rickettsia);
   • JRPD-ASY-0109 Burkholderia ssp. (Burkholderia);
   • JRPD-ASY-0112 Eastern equine encephalitis (EEE);
   • JRPD-ASY-0113 Western equine encephalitis (WEE);
   • JRPD-ASY-0114 Venezuelan equine encephalitis (VEE);
   • JRPD-ASY-0122 Coxiella burnetii (Coxiella);
   • JRPD-ASY-0136 Influenza A/H5 IVD Detection Kit;
   • JRPD-ASY-0137 Influenza A/B IVD Detection Kit; or
   • JRPD-ASY-0138 Influenza A Subtype IVD Detection Kit;
3. Critical Reagent Polymerase (CRP) Chain Reactions (PCR) assay kits with Catalog-ID and Catalog-ID Product respectively as follows:
   • PCR-BRU-1FB-B-K Brucella Target 1 FastBlock Master Mix Biotinylated;
   • PCR-BRU-1FB-K Brucella Target 1 FastBlock Master Mix;
   • PCR-BRU-1R-K Brucella Target 1 LightCycler/RAPID Master Mix;
   • PCR-BURK-2FB-B-K Burkholderia Target 2 FastBlock Master Mix Biotinylated;
   • PCR-BURK-2FB-K Burkholderia Target 2 FastBlock Master Mix;
   • PCR-BURK-2R-K Burkholderia Target 2 LightCycler/RAPID Master Mix;
   • PCR-BURK-3FB-B-K Burkholderia Target 3 FastBlock Master Mix Biotinylated;
   • PCR-BURK-3FB-K Burkholderia Target 3 FastBlock Master Mix;
   • PCR-BURK-3R-K Burkholderia Target 3 LightCycler/RAPID Master Mix;
   • PCR-COX-1FB-B-K Coxiella burnetii Target 1 FastBlock Master Mix Biotinylated;
   • PCR-COX-1R-K Coxiella burnetii Target 1 LightCycler/RAPID Master Mix;
   • PCR-COX-2R-K Coxiella burnetii Target 2 LightCycler/RAPID Master Mix;
   • PCR-OP-1FB-B-K Orthopox Target 1 FastBlock Master Mix Biotinylated;
   • PCR-OP-1FB-K Orthopox Target 1 FastBlock Master Mix;
   • PCR-OP-1R-K Orthopox Target 1 LightCycler/RAPID Master Mix;
   • PCR-OP-2FB-B-K Orthopox Target 2 FastBlock Master Mix Biotinylated;
   • PCR-OP-3R-K Orthopox Target 3 LightCycler/RAPID Master Mix;
   • PCR-RAZOR-BT-X PCR-RAZOR-BT-X RAZOR CRP BioThreat-X Screening Pouch;
   • PCR-RIC-1FB-K Ricin Target 1 FastBlock Master Mix;
   • PCR-RIC-1R-K Ricin Target 1 LightCycler/RAPID Master Mix;
   • PCR-RIC-2R-K Ricin Target 2 LightCycler/RAPID Master Mix; or
   • PCR-VEE-1R-K Venezuelan equine encephalitis Target 1 LightCycler/RAPID Master Mix
4. Critical Reagent Program Antibodies with Catalog ID and Product respectively as follows:
   • AB-AG-RIC Aff. Goat anti-Ricin;
   • AB-ALVG-MAB Anti-Alphavirus Generic Mab;
   • AB-AR-SEB Aff. Rabbit anti-SEB;
   • AB-BRU-M-MAB1 Anti-Brucella melitensis Mab 1;
   • AB-BRU-M-MAB2 Anti-Brucella melitensis Mab 2;
   • AB-BRU-M-MAB3 Anti-Brucella melitensis Mab 3;
   • AB-BRU-M-MAB4 Anti-Brucella melitensis Mab 4;
   • AB-CHOL-0139-MAB Anti-V.cholerae 0139 Mab;
   • AB-CHOL-01-MAB Anti-V. cholerae 01 Mab;
   • AB-EEE-MAB Anti-EEE Mab;
   • AB-G-BRU-A Goat anti-Brucella abortus;
   • AB-G-BRU-M Goat anti-Brucella melitensis;
   • AB-G-BRU-S Goat anti-Brucella suis;
   • AB-G-CHOL-01 Goat anti-V.cholerae 0:1;
   • AB-G-COL-139 Goat anti-V.cholerae 0:139;
   • AB-G-DENG Goat anti-Dengue;
   • AB-G-RIC Goat anti-Ricin;
   • AB-G-SAL-T Goat anti-S. typhi;
   • AB-G-SEA Goat anti-SEA;
   • AB-G-SEB Goat anti-SEB;
   • AB-G-SEC Goat anti-SEC;
   • AB-G-SED Goat anti-SED;
   • AB-G-SEE Goat anti-SEE;
   • AB-G-SHIG-D Goat anti-Shigella dysenteriae;
   • AB-R-BA-PA Rabbit anti-Protective Antigen;
   • AB-R-COX Rabbit anti-C. burnetii;
   • AB-RIC-MAB1 Anti-Ricin Mab 1;
   • AB-RIC-MAB2 Anti-Ricin Mab 2;
   • AB-RIC-MAB3 Anti-Ricin Mab3;
   • AB-R-SEB Rabbit anti-SEB;
   • AB-R-VACC Rabbit anti-Vaccinia;
   • AB-SEB-MAB Anti-SEB Mab;
   • AB-SLT2-MAB Anti-Shigella-like t x2 Mab;
   • AB-T2T-MAB1 Anti-T2 Mab 1;
   • AB-T2T-MAB2 Anti-T2 Toxin 2;
   • AB-VACC-MAB1 Anti-Vaccinia Mab 1;
   • AB-VACC-MAB2 Anti-Vaccinia Mab 2;
   • AB-VACC-MAB3 Anti-Vaccinia Mab 3;
   • AB-VACC-MAB4 Anti-Vaccinia Mab 4;
   • AB-VACC-MAB5 Anti-Vaccinia Mab 5;
   • AB-VACC-MAB6 Anti-Vaccinia Mab 6;
   • AB-VEE-MAB1 Anti-VEE Mab 1;
   • AB-VEE-MAB2 Anti-VEE Mab 2;
   • AB-VEE-MAB3 Anti-VEE Mab 3;
   • AB-VEE-MAB4 Anti-VEE Mab 4;
   • AB-VEE-MAB5 Anti-VEE Mab 5;
   • AB-VEE-MAB6 Anti-VEE Mab 6; or
   • AB-WEE-MAB Anti-WEE Complex Mab.

• Recombinant Botulinum ToxinA/B Vaccine;
• Recombinant Plague Vaccine;
• Trivalent Filovirus Vaccine; or
• Vaccines specially designed for the sole purpose of protecting against biological agents and biologically derived substances identified in paragraph (b) of this category.

• (C.A.S. #7784–34–1) Arsenic trichloride;
• (C.A.S. #76–93–7) Benzilic acid;
• (C.A.S. #78–38–6) Diethyl ethylphosphonate;
• (C.A.S. #683–08–9) Diethyl methylphosphonate;
• (C.A.S. #15715–41–0) Diethyl methylphosphonite;
• (C.A.S. #2404–03–7) Diethyl-N,Ndimethylphosphoroamidate;
• (C.A.S. #41480–75–5) N,NDiisopropylaminoethanethiol hydrochloride;
• (C.A.S. #5842–07–9) N,N-Diisopropylbeta-aminoethane thiol;
• (C.A.S. #96–80–0) N,N-Diisopropylbeta-aminoethanol;
• (C.A.S. #96–79–7), N,N-Diisopropylbeta-aminoethyl chloride;
• (C.A.S. #4261–68–1) N,NDiisopropyl-beta-aminoethyl chloride hydrochloride;
• (C.A.S. #6163–75–3) Dimethyl ethylphosphonate;
• (C.A.S. #756–79–6) Dimethyl methylphosphonate;
• (C.A.S. #677–43–0) N,Ndimethylamino-phosphoryl dichloride;
• (C.A.S. #1498–40–4) Ethyl phosphonous dichloride [Ethylphosphinyl dichloride];
• (C.A.S. #430–78–4) Ethyl phosphonus difluoride [Ethylphosphinyl difluoride];
• (C.A.S. #1066–50–8) Ethyl phosphonyl dichloride;
• (C.A.S. #993–13–5) Methylphosphonic acid;
• (C.A.S. #676–98–2) Methylphosphonothioic dichloride;
• (C.A.S. #464–07–3) Pinacolyl alcohol;
• (C.A.S. #1619–34–7) 3-Quinuclidinol;
• (C.A.S. #111–48–8) Thiodiglycol.
• (C.A.S. #762–04–9) Diethyl phosphite;
• (C.A.S. #868–85–9) Dimethyl phosphite (dimethyl hydrogenphosphite);
• (C.A.S. #139–87–7) Ethyldiethanolamine;
• (C.A.S. #10025–87–3) Phosphorus oxychloride;
• (C.A.S. #7719–12–2) Phosphorus trichloride;
• (C.A.S. #10545–99–0) Sulfur dichloride;
• (C.A.S. #10025–67–9) Sulfur monochloride;
• (C.A.S. #7719–09–7) Thionyl chloride;
• (C.A.S. #102–71–6) Triethanolamine;
• (C.A.S. #122–52–1) Triethyl phosphite;
• (C.A.S. #121–45–9) Trimethyl phosphite.
• (C.A.S. #1341–49–7) Ammonium hydrogen fluoride;
• (C.A.S. #107–07–3) 2-Chloroethanol;
• (C.A.S. #109–89–7) Diethylamine;
• (C.A.S. #100–37–8) N,NDiethylaminoethanol;
• (C.A.S. #589–57–1) Diethyl chlorophosphite;
• (C.A.S. #298–06–6) O,O-Diethyl phosphorodithioate;
• (C.A.S. #2465–65–8) O,O-Diethyl phosphorothioate;
• (C.A.S. #108–18–9) Di-isopropylamine;
• (C.A.S. #124–40–3) Dimethylamine;
• (C.A.S. #506–59–2) Dimethylamine hydrochloride;
• (C.A.S. #762–77–6) Ethyl chlorofluorophosphate;
• (C.A.S. #1498–51–7) Ethyl dichlorophosphate;
• (C.A.S. #460–52–6) Ethyl difluorophosphate;
• (C.A.S. #7664–39–3) Hydrogen fluoride;
• (C.A.S. #3554–74–3) 3-Hydroxyl-1-methylpiperidine;
• (C.A.S. #76–89–1) Methyl benzilate;
• (C.A.S. #754–01–8) Methyl chlorofluorophosphate;
• (C.A.S. #677–24–7) Methyl dichlorophosphate;
• (C.A.S. #22382–13–4) Methyl difluorophosphate;
• (C.A.S. #14277–06–6) N,N Diethylacetamidine;
• (C.A.S. #53510–30–8) N,N Diethylbutanamidine;
• (C.A.S. #90324–67–7) N,N Diethylformamidine;
• (C.A.S. #1342789–47–2) N,N Diethylisobutanamidine;
• (C.A.S. #84764–73–8) N,N Diethylpropanamidine;
• (C.A.S. #1315467–17–4) N,N Diisopropylbutanamidine;
• (C.A.S. #857522–08–8) N,N Diisopropylformamidine;
• (C.A.S. #2909–14–0) N,N Dimethylacetamidine;
• (C.A.S. #1340437–35–5) N,N Dimethylbutanamidine;
• (C.A.S. #44205–42–7) N,N Dimethylformamidine;
• (C.A.S. #321881–25–8) N,N Dimethylisobutanamidine;
• (C.A.S. #56776–14–8) N,N Dimethylpropanamidine;
• (C.A.S. #1339586–99–0) N,N Dipropylacetamidine;
• (C.A.S. #1342422–35–8) N,N Dipropylbutanamidine;
• (C.A.S. #48044–20–8) N,N Dipropylformamidine;
• (C.A.S. #1342700–45–1) N,N Dipropylisobutanamidine;
• (C.A.S. #1341496–89–6) N,N Dipropylpropanamidine;
• (C.A.S. #1314–80–3) Phosphorus pentasulfide;
• (C.A.S. #75–97–8) Pinacolone;
• (C.A.S. #7789–29–9) Potassium bifluoride;
• (C.A.S. #151–50–8) Potassium cyanide;
• (C.A.S. #7789–23–3) Potassium fluoride;
• (C.A.S. #3731–38–2) 3-Quinuclidone;
• (C.A.S. #1333–83–1) Sodium bifluoride;
• (C.A.S. #143–33–9) Sodium cyanide;
• (C.A.S. #7681–49–4) Sodium fluoride;
• (C.A.S. #16893–85–9) Sodium hexafluorosilicate;
• (C.A.S. #1313–82–2) Sodium sulfide;
• (C.A.S. #637–39–8) Triethanolamine hydrochloride;
• (C.A.S. #116–17–6) Tri-isopropyl phosphite.

• (C.A.S. #382-21-8) 1,1,3,3,3-Pentafluoro-2-(trifluoromethyl)-1-propene (PFIB) and mixtures in which PFIB constitutes more than 1% of the mixtures weight;
• Precursor chemicals and mixtures in which at least one of the following precursor chemicals constitutes more than 10% of the weight of the mixture:
  • CWC Schedule 2 chemicals containing a phosphorus atom to which is bonded one methyl, ethyl, or propyl (normal or iso) group but not further carbon atoms;
  • N,N-Dialkyl (Me, Et, n-Pr or i-Pr) phosphoramidic dihalides;
  • Dialkyl (Me, Et, n-Pr or iPr) N,N-dialkyl (Me, Et, n-Pr, or i-Pr)-phosphoramidates;
  • N,N-Dialkyl (Me, Et, n-Pr or i-Pr) aminoethyl-2- chlorides and corresponding protonated salts;
  • N,N-Dialkyl (Me, Et, n-Pr or i-Pr) aminoethane-2- ols and corresponding protonated salts;
  • N,N-Dialkyl (Me, Et, n-Pr or i-Pr) aminoethane-2- thiols and corresponding protonated salts.

• Toxic chemicals and mixtures in which at least one of the following toxic chemicals constitutes 30% or more of the weight of the mixture:
  • (C.A.S. #75–44–5) Phosgene: Carbonyl dichloride;
  • (C.A.S. #506–77–4) Cyanogen chloride;
  • (C.A.S. #74–90–8) Hydrogen cyanide;
  • (C.A.S. #76–06–2) Chloropicrin: Trichloronitromethane.
• Precursor chemicals and mixtures in which at least one of the following precursor chemicals constitutes 30% or more of the weight of the mixture:
  • (C.A.S. #105–59–9) Methyldiethanolamine.